Oscar Histories was born on November 22, 1986, in South Africa. But he wasn't born the perfectly formed, healthy baby we all hope for. He was born with fibular hemimelia, a congenital disorder in which there is a complete or partial absence of the fibula. Sometimes, with fibular hemimelia, other deformities are also present in the ankle and foot, as well as in the femur, knee, and tibia. Pastries' fibular hemimelia led to a double-amputation of his legs below the knee when he was still an infant, partial amputation being a standard treatment for the disorder.
Histories' parents were advised to have the amputations done before he learned to walk, which would make it easier for him to adapt to the change and make it more likely for him to be mobile in the future. Histories not only learned to live with his disability, as he grew up, he excelled, becoming a determined athlete and competitor. At the age of 26, he has already become a world champion sprinter and made history. In August 2012, he represented South Africa in the London Olympic Games, becoming the first double amputee to compete in track and field.
Histories wear prosthetic legs. He received his first pair soon after his amputations, which allowed him to grow up competing in sports. Now those prosthetics are high-tech carbon-fibber blades, hence the nickname "Blade Runner." Pastries' success with prosthetics gives hope and encouragement too many that use prosthetic limbs or will have to in the future and to those who suffer from other foot and ankle disorders.
One of the most common diseases we see in our office that leads to amputations is diabetes, and with diabetes being a growing problem in the United States, it is something we see on a regular basis. Our main goal with diabetes is to prevent amputation, and there are many new techniques available to save feet and legs, but when amputation becomes a necessity, it is good for patients to know that with prosthetics available and with the advances in prosthetics; it is still possible to lead a normal life.